BIOMAT Database Logo BIOMAT Database Logo

DNA ploidy and other results of DNA flow cytometry as prognostic factors in operable breast cancer: 10 year results of a randomised study. 1992

M F Gnant, and G Blijham, and A Reiner, and G Reiner, and M Reynders, and B Schutte, and C van Asche, and G Steger, and R Jakesz
1st Department of Surgery, University of Vienna, Austria.

We evaluated breast cancer specimens from 241 patients of a controlled clinical trial by means of DNA flow cytometry. We report the correlations between DNA index (DNI) and fraction of cells in S-phase (SPF) and other prognostic parameters. Both univariately and in a Cox model, the predictive power of these factors is evaluated after a follow-up of more than 10 years. There are strong correlations between DNI and SPF (P = 0.0001) and between flow cytometry parameters and clinical and histopathological factors such as axillary lymph node involvement, tumour size and histological grade. In univariate analysis DNI fails to provide prognostic information, whereas SPF turns out to be able to differentiate between patients at high and low risk for relapse and death (P = 0.002). In the multivariate Cox model, too, SPF is an important prognostic parameter with respect to patient survival (relative risk: +86%), only surpassed by nodal involvement. DNI, however, turns out to be an independent predictor of relapse free survival and distant recurrence free survival. By combination of DNI and SPF, patients can be divided into three prognostic subgroups. We conclude that data from DNA flow cytometry can be of great importance for the decision on the level of aggressiveness of adjuvant therapy for an individual patient and therefore may help to avoid overtreatment and toxicity.

UI MeSH Term Description Entries
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011003 Ploidies The degree of replication of the chromosome set in the karyotype. Ploidy
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D005260 Female Females
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M F Gnant, and G Blijham, and A Reiner, and G Reiner, and M Reynders, and B Schutte, and C van Asche, and G Steger, and R Jakesz
DNA flow cytometry and other prognostic factors in breast cancer.
January 1990, Cancer investigation,
M F Gnant, and G Blijham, and A Reiner, and G Reiner, and M Reynders, and B Schutte, and C van Asche, and G Steger, and R Jakesz
Nuclear morphometry and DNA flow cytometry as prognostic factors in female breast cancer.
March 1992, The European journal of surgery = Acta chirurgica,
M F Gnant, and G Blijham, and A Reiner, and G Reiner, and M Reynders, and B Schutte, and C van Asche, and G Steger, and R Jakesz
Correlation of DNA flow cytometric results and other prognostic factors in primary breast cancer.
June 1988, International journal of cancer,
M F Gnant, and G Blijham, and A Reiner, and G Reiner, and M Reynders, and B Schutte, and C van Asche, and G Steger, and R Jakesz
DNA-flow cytometry (ploidy and s-phase fraction) as prognostic factor in a retrospective series of 515 primary breast-cancer.
May 1995, Oncology reports,
M F Gnant, and G Blijham, and A Reiner, and G Reiner, and M Reynders, and B Schutte, and C van Asche, and G Steger, and R Jakesz
DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens.
February 1988, Cancer,
M F Gnant, and G Blijham, and A Reiner, and G Reiner, and M Reynders, and B Schutte, and C van Asche, and G Steger, and R Jakesz
Peritumoral lymphatic vessel invasion compared with DNA ploidy, proliferative activity, and other pathologic features as prognostic indicators in operable breast cancer.
March 1992, Breast cancer research and treatment,
M F Gnant, and G Blijham, and A Reiner, and G Reiner, and M Reynders, and B Schutte, and C van Asche, and G Steger, and R Jakesz
[Breast cancer and flow cytometry: comparative study of DNA ploidy pattern with clinicopathological parameters].
June 1994, Revista medica de Chile,
M F Gnant, and G Blijham, and A Reiner, and G Reiner, and M Reynders, and B Schutte, and C van Asche, and G Steger, and R Jakesz
[Proliferative activity and ploidy of DNA as possible prognostic factors in breast cancer].
January 1996, Klinicheskaia laboratornaia diagnostika,
M F Gnant, and G Blijham, and A Reiner, and G Reiner, and M Reynders, and B Schutte, and C van Asche, and G Steger, and R Jakesz
Prognostic value of DNA ploidy as assessed with flow cytometry in uveal melanoma.
December 1995, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie,
M F Gnant, and G Blijham, and A Reiner, and G Reiner, and M Reynders, and B Schutte, and C van Asche, and G Steger, and R Jakesz
DNA analysis of breast cancer by flow cytometry & correlation with other prognostic parameters.
August 1992, The Indian journal of medical research,
Copied contents to your clipboard!